SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹50 Cr | ₹-7.06 Cr | ₹62 Cr | ₹63 Cr | ₹32 Cr |
What is the latest Consolidated Net Profit of SMS PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹50 Cr |
Mar2023 | ₹-7.06 Cr |
Mar2022 | ₹62 Cr |
Mar2021 | ₹63 Cr |
Mar2020 | ₹32 Cr |
How is Consolidated Net Profit of SMS PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹50 Cr | Positive | |
Mar2023 | ₹-7.06 Cr | Negative | |
Mar2022 | ₹62 Cr | -0.49 | |
Mar2021 | ₹63 Cr | 98.03 | |
Mar2020 | ₹32 Cr | - |
Compare Consolidated Net Profit of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹2,305.8 Cr | -3.5% | 6.1% | 22.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,125.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,358.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,957.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,087.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,197.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | -3.5% |
6.1% |
22.6% |
SENSEX | -1% |
0.3% |
7.4% |
You may also like the below Video Courses